Current NDC auxiliary source row compounder:3839

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 71285-0206
Product Ndc: 71285-0206
Product Ndc Digits: 712850206
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Induction 4 to1 High K (48 meq) in RL
Proprietary Name Suffix: [empty]
Nonproprietary Name: Induction 4 to1 High K (48 meq) in RL
Dosage Form Name: SOLUTION
Route Name: INTRACORONARY
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Central Admixture Pharmacy Services, Inc.
Establishment Name: Central Admixture Pharmacy Services, Inc.
Establishment Fei: [empty]
Substance Name: CALCIUM CHLORIDE; SODIUM CHLORIDE; POTASSIUM CHLORIDE; MANNITOL; LIDOCAINE HYDROCHLORIDE; SODIUM BICARBONATE
Active Ingredients Info: .105 g/522.8 mL; 2.743 g/522.8 mL; 3.672 g/522.8 mL; 31.26 g/522.8 mL; 250 mg/522.8 mL; .924 g/522.8 mL
History Active Ingredients Raw: CALCIUM CHLORIDE; SODIUM CHLORIDE; POTASSIUM CHLORIDE; MANNITOL; LIDOCAINE HYDROCHLORIDE; SODIUM BICARBONATE
History Active Ingredients Info Raw: .105 g/522.8 mL; 2.743 g/522.8 mL; 3.672 g/522.8 mL; 31.26 g/522.8 mL; 250 mg/522.8 mL; .924 g/522.8 mL
History Dosage Raw: SOLUTION
Dea Schedule: [empty]
Package Ndc Raw: 71285-0206-1
Package Ndc: 71285-0206-1
Package Ndc Digits: 7128502061
Package Ndc11: 71285020601
Package Description: 522.8 mL in 1 BAG (71285-0206-1)
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:3839
Source Row Number: 3839
Source Row Hash: 412c2e3bdfb128e0ff1bfd379bba740fc8d0db8a93e56dd28542ad068841e8fb
Import Run Id: 20261025T224840Z
Loaded At: 2026-10-25 22:53:27

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRACORONARY",
    "PRODUCTNDC": "71285-0206",
    "DEASCHEDULE": "",
    "LABELERNAME": "Central Admixture Pharmacy Services, Inc.",
    "SUBSTANCENAME": "CALCIUM CHLORIDE; SODIUM CHLORIDE; POTASSIUM CHLORIDE; MANNITOL; LIDOCAINE HYDROCHLORIDE; SODIUM BICARBONATE",
    "DOSAGEFORMNAME": "SOLUTION",
    "NDCPACKAGECODE": "71285-0206-1",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Induction 4 to1 High K (48 meq) in RL",
    "REPORTINGPERIOD": "2024-2",
    "NONPROPRIETARYNAME": "Induction 4 to1 High K (48 meq) in RL",
    "PACKAGEDESCRIPTION": "522.8 mL in 1 BAG (71285-0206-1) ",
    "ACTIVEINGREDIENTSINFO": ".105 g/522.8 mL; 2.743 g/522.8 mL; 3.672 g/522.8 mL; 31.26 g/522.8 mL; 250 mg/522.8 mL; .924 g/522.8 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:3839
Source Row Number: 3839
Status Scope: package
Lookup Ndc: 71285-0206-1
Lookup Ndc Digits: 7128502061
Product Ndc: 71285-0206
Product Ndc Digits: 712850206
Package Ndc: 71285-0206-1
Package Ndc Digits: 7128502061
Package Ndc11: 71285020601
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 412c2e3bdfb128e0ff1bfd379bba740fc8d0db8a93e56dd28542ad068841e8fb
Import Run Id: 20261025T224840Z
Loaded At: 2026-10-25 22:53:27